AnalystsRobert DriscollRobert Driscoll's Stock Forecasts
AnalystsRobert Driscoll
Sectors:
Industries:
Analyst Ranking
Top 1%
#43 out of 4571 analysts
Average Return
+40.56%
Win Rate
50%55 out of 111
Risk vs Reward
Poor
Good
Robert Driscoll's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Janux Therapeutics IncJANX | +761.03% | $6.62 | $57.00 | 2023-11-07 - 2024-04-30 | Buy |
Elevation Oncology IncELEV | +615.73% | $0.50 | $3.55 | 2023-11-05 - 2024-04-30 | Buy |
Five Prime Therapeutics IncFPRX | +494.68% | $6.39 | $38.00 | 2020-06-21 - 2021-04-15 | Buy |
Alpine Immune Sciences IncALPN | +411.40% | $12.63 | $64.59 | 2023-11-14 - 2024-04-30 | Buy |
Alpine Immune Sciences IncALPN | +400.70% | $12.90 | $64.59 | 2023-08-31 - 2024-04-30 | Buy |
Robert Driscoll Analyst Color
Get additional color on Robert Driscoll's coverage of popular stocks
Robert Driscoll's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Adicet Bio IncACET | 7 | Buy | $5.00 | +235.57% | Reiterates | 8 days ago |
Geron CorpGERN | 7 | Buy | $6.00 | +52.67% | Reiterates | 21 days ago |
Foghorn Therapeutics IncFHTX | 5 | Buy | $13.00 | +138.10% | Reiterates | 22 days ago |
Black Diamond Therapeutics IncBDTX | 6 | Buy | $16.00 | +187.25% | Maintains | 23 days ago |
Aprea Therapeutics IncAPRE | 2 | Buy | $11.00 | +115.69% | Maintains | a month ago |
Compass Therapeutics IncCMPX | 2 | Buy | $8.00 | +455.56% | Reiterates | a month ago |
Tyra Biosciences IncTYRA | 4 | Buy | $28.00 | +63.74% | Reiterates | a month ago |
Alpine Immune Sciences IncALPN | 6 | Buy | $47.00 | -27.23% | Reiterates | a month ago |
Cytomx Therapeutics IncCTMX | 6 | Hold | $3.00 | +84.05% | Reiterates | 2 months ago |
Igm Biosciences IncIGMS | 6 | Buy | $20.00 | +107.68% | Reiterates | 2 months ago |
Elevation Oncology IncELEV | 6 | Buy | $8.00 | +125.35% | Maintains | 2 months ago |
Kura Oncology IncKURA | 4 | Buy | $37.00 | +88.58% | Reiterates | 2 months ago |
Zentalis Pharmaceuticals IncZNTL | 8 | Hold | $15.00 | +35.62% | Maintains | 2 months ago |
Arvinas IncARVN | 4 | Buy | $59.00 | +85.71% | Maintains | 2 months ago |
Arcus Biosciences IncRCUS | 4 | Buy | $30.00 | +96.98% | Reiterates | 2 months ago |
Cullinan Therapeutics IncCGEM | 1 | Buy | $30.00 | +11.07% | Initiates Coverage On | 3 months ago |
Monte Rosa Therapeutics IncGLUE | 1 | Buy | $11.00 | +106.77% | Initiates Coverage On | 3 months ago |
Omega Therapeutics IncOMGA | 3 | Buy | $12.00 | +438.12% | Reiterates | 4 months ago |
Ideaya Biosciences IncIDYA | 5 | Buy | $43.00 | +5.78% | Reiterates | 6 months ago |
Replimune Group IncREPL | 4 | Buy | $52.00 | +718.90% | Reiterates | 6 months ago |
Janux Therapeutics IncJANX | 5 | Buy | $24.00 | -57.89% | Reiterates | 6 months ago |
Day One Biopharmaceuticals IncDAWN | 5 | Buy | $35.00 | +104.68% | Maintains | 6 months ago |
Werewolf Therapeutics IncHOWL | 1 | Buy | $9.00 | +44.23% | Initiates Coverage On | 8 months ago |
Atreca IncBCEL | 4 | Hold | $1.00 | +566.67% | Downgrades | 9 months ago |
Cyteir Therapeutics IncCYTT | 3 | Buy | $3.00 | -0.66% | Reiterates | a year ago |
Tango Therapeutics IncTNGX | 2 | Buy | $18.00 | +133.77% | Reiterates | a year ago |
Surface Oncology IncSURF | 1 | Buy | $3.00 | N/A | Reiterates | a year ago |
Imago Biosciences IncIMGO | 2 | Hold | $36.00 | N/A | Downgrades | a year ago |
Harpoon Therapeutics IncHARP | 3 | Buy | $70.00 | N/A | Upgrades | 2 years ago |
Entasis Therapeutics Holdings IncETTX | 1 | Hold | $1.80 | N/A | Downgrades | 2 years ago |
Aceragen IncACGN | 2 | Hold | $1.00 | N/A | Downgrades | 3 years ago |
Five Prime Therapeutics IncFPRX | 4 | Buy | $9.00 | N/A | Upgrades | 4 years ago |
Arbutus Biopharma CorpABUS | 4 | Buy | $4.00 | N/A | Upgrades | 4 years ago |
Nabriva Therapeutics PLCNBRVF | 1 | Hold | $250.00 | N/A | Downgrades | 4 years ago |
Paratek Pharmaceuticals IncPRTK | 1 | Buy | $34.00 | N/A | Reiterates | 7 years ago |
Sierra Oncology IncSRRA | 1 | Buy | $4.00 | N/A | Upgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.